Qing Liu
Boston
Education
Ph.D. and M.S., epidemiology, Brown University; B.S./M.D., preventative medicine, Peking University
Summary of Experience
Dr. Liu is an epidemiologist with expertise in biostatistics, clinical medicine, and public health. She has experience with real-world data analyses, including administrative claims and hospital-based database analyses, clinical trial analyses, and pharmacoeconomic modeling. Her research focuses on the evaluation and comparison of clinical and economic outcomes in a broad range of therapeutic areas, including hematology, oncology, rheumatology, and infectious diseases and vaccines. Dr. Liu’s work includes cost-effectiveness analyses, systematic literature reviews, comparative effectiveness research, and studies evaluating health care resource use and costs. Her work has been published in peer-reviewed journals and presented at conferences on medical and health care research. Prior to joining Analysis Group, Dr. Liu was a graduate student researcher at Brown University, where she focused on the interaction of genetic variants and dietary lipids in the field of cardio-metabolic health outcomes.
Selected Publishing
-
Economic Burden of Acute Otitis Media, Pneumonia, and Invasive Pneumococcal Disease in Children in the United States after the Introduction of 13-Valent Pneumococcal Conjugate Vaccines During 2014-2018
BMC Health Services Research, 2023
2023Hu T, Song Y, Done N, Mohanty S, Liu Q, Sarpong EM, Lemus-Wirtz E, Signorovitch J, Weiss T
-
Incidence of Non-Invasive All-Cause Pneumonia in Children in the United States before and after the Introduction of Pneumococcal Conjugate Vaccines: A Retrospective Claims Database Analysis
Pneumonia, 2023
2023Hu T, Sarpong EM, Song Y, Done N, Liu Q, Lemus-Wirtz E, Signorovitch J, Mohanty S, Weiss T
-
Healthcare costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspective
Blood Advances, 2023
2023Maziarz RT, Gergis U, Edwards ML, Song Y, Liu Q, Anderson A, Signorovitch JE, Manghani R, Simantov R, Shin H, Sivaraman S
-
Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood
Transplantation and Cellular Therapy, 2022
2022Lin C, Sajeev G, Stiff PJ, Brunstein CG, Cutler C, Sanz G, Lindemans CA, Rezvani AR, Hanna R, Koh LP, Maziarz RT, Hwang WYK, Song Y, Liu Q, Manghani R, Sivaraman S, Signorovitch J, Horwitz ME, Sung AD
-
Incidence of invasive pneumococcal disease in children with commercial insurance or Medicaid coverage in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998-2018
BMC Public Health, 2022
2022Hu T, Song Y, Done N, Liu Q, Sarpong EM, Lemus-Wirtz E, Signorovitch J, Mohanty S, Weiss T
-
Real-world healthcare resource utilization and costs associated with tisagenlecleucel and axicabtagene ciloleucel among patients with diffuse large B-cell lymphoma: an analysis of hospital data in the United States
Leukemia & Lymphoma, 2022
2022Maziarz RT, Yang H, Liu Q, Wang T, Zhao J, Lim S, Lee S, Dalal A, Bollu V
-
Incidence of acute otitis media in children in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998-2018
BMS Infectious Diseases, 2022
2022Hu T, Done N, Petigara T, Mohanty S, Song Y, Liu Q, Lemus-Wirtz E, Signorovitch J, Sarpong E, Weiss T
-
Cost Effectiveness Analysis of Tisagenlecleucel for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma in Japan
Transplantation and Cellular Therapy, 2021
2021Wakase S, Teshima T, Zhang J, Ma Q, Fujita T, Yang H, Chai X, Qi CZ, Liu Q, Wu EQ, Igarashi A